Casandra
Casandra Test Code QD02747Version 1 (DRAFT)
Performing Lab
Drug Monitoring, MDMA/MDA, Quantitative, Urine
Also known as: Pain Management, Prescription Drug Monitoring
Clinical Use
Order TestUse
This test provides quantitative measurement of MDMA (3,4‑methylenedioxymethamphetamine) and its metabolite MDA in urine. It supports therapeutic drug monitoring for compliance, as well as detecting illicit use of MDMA. Quantitative results are useful in definitive monitoring but should not be used to infer dosage due to metabolic and excretion variability. It is performed as a definitive assay using mass spectrometry.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Mass Spectrometry
Biomarkers
MDA
AnalyteMDA • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
MDMA
AnalyteMDMA • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Urine
Volume
10 mL (9 mL minimum)
Minimum Volume
9 mL
Container
plastic urine container
Storage Instructions
Room temperature
Causes for Rejection
Preserved urine
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 5 days |
| Refrigerated | 7 days |
| Frozen | 30 days |